Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where L. Keoki Williams is active.

Publication


Featured researches published by L. Keoki Williams.


Nature Genetics | 2011

Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations

Dara G. Torgerson; Elizabeth J. Ampleford; Grace Y. Chiu; W. James Gauderman; Christopher R. Gignoux; Penelope E. Graves; Blanca E. Himes; A. Levin; Rasika A. Mathias; Dana B. Hancock; James W. Baurley; Celeste Eng; Debra A. Stern; Juan C. Celedón; Nicholas Rafaels; Daniel Capurso; David V. Conti; Lindsey A. Roth; Manuel Soto-Quiros; Alkis Togias; Xingnan Li; Rachel A. Myers; Isabelle Romieu; David Van Den Berg; Donglei Hu; Nadia N. Hansel; Ryan D. Hernandez; Elliott Israel; Muhammad T. Salam; Joshua M Galanter

Asthma is a common disease with a complex risk architecture including both genetic and environmental factors. We performed a meta-analysis of North American genome-wide association studies of asthma in 5,416 individuals with asthma (cases) including individuals of European American, African American or African Caribbean, and Latino ancestry, with replication in an additional 12,649 individuals from the same ethnic groups. We identified five susceptibility loci. Four were at previously reported loci on 17q21, near IL1RL1, TSLP and IL33, but we report for the first time, to our knowledge, that these loci are associated with asthma risk in three ethnic groups. In addition, we identified a new asthma susceptibility locus at PYHIN1, with the association being specific to individuals of African descent (P = 3.9 × 10−9). These results suggest that some asthma susceptibility loci are robust to differences in ancestry when sufficiently large samples sizes are investigated, and that ancestry-specific associations also contribute to the complex genetic architecture of asthma.


The Journal of Allergy and Clinical Immunology | 2011

Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence.

L. Keoki Williams; Edward L. Peterson; Karen Wells; Brian K. Ahmedani; Rajesh Kumar; Esteban G. Burchard; Vimal K. Chowdhry; David Favro; David E. Lanfear; Manel Pladevall

BACKGROUND Asthma is an inflammatory condition often punctuated by episodic symptomatic worsening, and accordingly, patients with asthma might have waxing and waning adherence to controller therapy. OBJECTIVE We sought to measure changes in inhaled corticosteroid (ICS) adherence over time and to estimate the effect of this changing pattern of use on asthma exacerbations. METHODS ICS adherence was estimated from electronic prescription and fill information for 298 participants in the Study of Asthma Phenotypes and Pharmacogenomic Interactions by Race-Ethnicity. For each patient, we calculated a moving average of ICS adherence for each day of follow-up. Asthma exacerbations were defined as the need for oral corticosteroids, an asthma-related emergency department visit, or an asthma-related hospitalization. Proportional hazard models were used to assess the relationship between ICS medication adherence and asthma exacerbations. RESULTS Adherence to ICS medications began to increase before the first asthma exacerbation and continued afterward. Adherence was associated with a reduction in exacerbations but was only statistically significant among patients whose adherence was greater than 75% of the prescribed dose (hazard ratio, 0.61; 95% CI, 0.41-0.90) when compared with patients whose adherence was 25% or less. This pattern was largely confined to patients whose asthma was not well controlled initially. An estimated 24% of asthma exacerbations were attributable to ICS medication nonadherence. CONCLUSIONS ICS adherence varies in the time period leading up to and after an asthma exacerbation, and nonadherence likely contributes to a large number of these exacerbations. High levels of adherence are likely required to prevent these events.


Diabetes Care | 2006

A Single Factor Underlies the Metabolic Syndrome: A confirmatory factor analysis

Manel Pladevall; Bonita Singal; L. Keoki Williams; Carlos Brotons; Heidi Guyer; J. Sadurni; Carles Falces; Manuel Serrano-Ríos; Rafael Gabriel; Jonathan E. Shaw; Paul Zimmet; Steven M. Haffner

OBJECTIVE Confirmatory factor analysis (CFA) was used to test the hypothesis that the components of the metabolic syndrome are manifestations of a single common factor. RESEARCH DESIGN AND METHODS Three different datasets were used to test and validate the model. The Spanish and Mauritian studies included 207 men and 203 women and 1,411 men and 1,650 women, respectively. A third analytical dataset including 847 men was obtained from a previously published CFA of a U.S. population. The one-factor model included the metabolic syndrome core components (central obesity, insulin resistance, blood pressure, and lipid measurements). We also tested an expanded one-factor model that included uric acid and leptin levels. Finally, we used CFA to compare the goodness of fit of one-factor models with the fit of two previously published four-factor models. RESULTS The simplest one-factor model showed the best goodness-of-fit indexes (comparative fit index 1, root mean-square error of approximation 0.00). Comparisons of one-factor with four-factor models in the three datasets favored the one-factor model structure. The selection of variables to represent the different metabolic syndrome components and model specification explained why previous exploratory and confirmatory factor analysis, respectively, failed to identify a single factor for the metabolic syndrome. CONCLUSIONS These analyses support the current clinical definition of the metabolic syndrome, as well as the existence of a single factor that links all of the core components.


The New England Journal of Medicine | 2010

Genetic ancestry in lung-function predictions

Rajesh Kumar; Max A. Seibold; Melinda C. Aldrich; L. Keoki Williams; Alex P. Reiner; Laura A. Colangelo; Joshua M. Galanter; Christopher R. Gignoux; Donglei Hu; Saunak Sen; Shweta Choudhry; Edward L. Peterson; Jose R. Rodriguez-Santana; William Rodriguez-Cintron; Michael A. Nalls; Tennille S. Leak; Ellen S. O'Meara; Bernd Meibohm; Stephen B. Kritchevsky; Rongling Li; Tamara B. Harris; Deborah A. Nickerson; Myriam Fornage; Paul L. Enright; Elad Ziv; Lewis J. Smith; Kiang Liu; Esteban G. Burchard

BACKGROUND Self-identified race or ethnic group is used to determine normal reference standards in the prediction of pulmonary function. We conducted a study to determine whether the genetically determined percentage of African ancestry is associated with lung function and whether its use could improve predictions of lung function among persons who identified themselves as African American. METHODS We assessed the ancestry of 777 participants self-identified as African American in the Coronary Artery Risk Development in Young Adults (CARDIA) study and evaluated the relation between pulmonary function and ancestry by means of linear regression. We performed similar analyses of data for two independent cohorts of subjects identifying themselves as African American: 813 participants in the Health, Aging, and Body Composition (HABC) study and 579 participants in the Cardiovascular Health Study (CHS). We compared the fit of two types of models to lung-function measurements: models based on the covariates used in standard prediction equations and models incorporating ancestry. We also evaluated the effect of the ancestry-based models on the classification of disease severity in two asthma-study populations. RESULTS African ancestry was inversely related to forced expiratory volume in 1 second (FEV(1)) and forced vital capacity in the CARDIA cohort. These relations were also seen in the HABC and CHS cohorts. In predicting lung function, the ancestry-based model fit the data better than standard models. Ancestry-based models resulted in the reclassification of asthma severity (based on the percentage of the predicted FEV(1)) in 4 to 5% of participants. CONCLUSIONS Current predictive equations, which rely on self-identified race alone, may misestimate lung function among subjects who identify themselves as African American. Incorporating ancestry into normative equations may improve lung-function estimates and more accurately categorize disease severity. (Funded by the National Institutes of Health and others.)


The Journal of Clinical Endocrinology and Metabolism | 2010

Thiazolidinedione Use and the Longitudinal Risk of Fractures in Patients with Type 2 Diabetes Mellitus

Zeina A. Habib; Suzanne Havstad; Karen Wells; George Divine; Manel Pladevall; L. Keoki Williams

CONTEXT Thiazolidinedione (TZD) use has recently been associated with an increased risk of fractures. OBJECTIVE The aim of this study was to determine the time-dependent relationship between TZD use and fracture risk. DESIGN We conducted a retrospective cohort study in a large health system in southeast Michigan. PATIENTS PATIENTS who received care from the health system were included if they were at least 18 yr of age, had a diagnosis of diabetes, and had at least one prescription for an oral diabetes medication. These criteria identified 19,070 individuals (9,620 women and 9,450 men). INTERVENTION This study compared patients treated with TZDs to patients without TZD treatment. Cox proportional hazard models were used to assess the relationship between exposure and outcomes. MAIN OUTCOME MEASURES The primary outcome was the time to fracture. Secondary analyses examined the risk of fractures in subgroups defined by sex and age. RESULTS TZD use was associated with an increased risk of fracture in the cohort overall [adjusted hazard ratio (aHR), 1.35; 95% confidence interval (CI), 1.05-1.71] and in women (aHR, 1.57; 95% CI, 1.16-2.14), but not in men (aHR, 1.05; 95% CI, 0.70-1.58). Women more than 65 yr of age appeared to be at greatest risk for fracture (aHR, 1.72; 95% CI, 1.17-2.52). Among women, the increased fracture risk was not apparent until after 1 yr of TZD treatment. CONCLUSIONS TZD use was associated with an increased risk for fractures in women, particularly at ages above 65 yr. Clinicians should be aware of this association when considering TZD therapy so as to appropriately manage and counsel their patients.


Obesity | 2006

Long-Term Effects of Obesity on Employment and Work Limitations Among U.S. Adults, 1986 to 1999

Kaan Tunceli; Kemeng Li; L. Keoki Williams

Objective: To determine the relationships between BMI and workforce participation and the presence of work limitations in a U.S. working‐age population.


Human Molecular Genetics | 2008

An african-specific functional polymorphism in KCNMB1 shows sex-specific association with asthma severity

Max A. Seibold; Bin Wang; Celeste Eng; Gunjan Kumar; Kenneth B. Beckman; Saunak Sen; Shweta Choudhry; Kelley Meade; Michael LeNoir; H. Geoffrey Watson; Shannon Thyne; L. Keoki Williams; Rajesh Kumar; Kevin B. Weiss; Leslie C. Grammer; Pedro C. Avila; Robert P. Schleimer; Esteban G. Burchard; Robert Brenner

A highly heritable and reproducible measure of asthma severity is baseline pulmonary function. Pulmonary function is largely determined by airway smooth muscle (ASM) tone and contractility. The large conductance, voltage and calcium-activated potassium (BK) channel negatively regulates smooth muscle tone and contraction in ASM. The modulatory subunit of BK channels, the beta1-subunit, is critical for proper activation of BK channels in smooth muscle and has shown sex hormone specific regulation. We hypothesized that KCNMB1 genetic variants in African Americans may underlie differences in bronchial smooth muscle tone and thus pulmonary function, possibly in a sex-specific manner. Through resequencing of the KCNMB1 gene we identified several common variants including a novel African-specific coding polymorphism (C818T, R140W). The C818T SNP and four other KCNMB1 variants were genotyped in two independent groups of African American asthmatics (n = 509) and tested for association with the pulmonary function measure--forced expiratory volume (FEV(1)) % of predicted value. The 818T allele is associated with a clinically significant decline (-13%) in FEV(1) in both cohorts of asthmatics among males but not females (P(combined) = 0.0003). Patch clamp electrophysiology studies of the BK channel expressed with the 140Trp variant of the beta1-subunit demonstrated significantly reduced channel openings, predicted by the loss of pulmonary function observed. African American male asthmatics carrying the 818T allele (10% of population) are potentially at risk for greater airway obstruction and increased asthma morbidity. Female asthmatics may be insulated from the deleterious effects of the 818T allele by estrogen-mediated upregulation in BK channel activity.


American Journal of Respiratory and Critical Care Medicine | 2008

Race-Ethnic Differences in Factors Associated with Inhaled Steroid Adherence among Adults with Asthma

Karen Wells; Manel Pladevall; Edward L. Peterson; Janis Campbell; Mingqun Wang; David E. Lanfear; L. Keoki Williams

RATIONALE Adherence to inhaled corticosteroid (ICS) medication is known to be low overall, but tends to be lower among African-American patients when compared with white patients. OBJECTIVES To understand the factors that contribute to ICS adherence among African-American and white adults with asthma. METHODS Eligible individuals had a prior diagnosis of asthma, one or more ICS prescriptions, and were members of a large health maintenance organization in southeast Michigan. Individuals were sent a survey that included questions about internal factors (e.g., patient beliefs, knowledge, and motivation) and external factors (e.g., socioeconomic status, barriers to care, social support, and stressors) potentially related to ICS adherence. Adherence was calculated using electronic prescription and fill data. Stepwise regression was used to identify factors associated with adherence before and after stratifying by race-ethnicity. MEASUREMENTS AND MAIN RESULTS Surveys were returned by 1,006 (56.3%) of 1,787 eligible patients. Adjusting for internal factors, but not external factors, diminished the relationship between race-ethnicity and ICS adherence. Among African-American patients, readiness to take ICS medication was the only internal or external factor significantly associated with ICS adherence; it explained 5.6% of the variance in adherence. Among white patients, perceived ICS necessity, ICS knowledge, doctors being perceived as the source of asthma control, and readiness to take medication were the internal factors associated with ICS adherence; these accounted for 19.8% of the variance in adherence. CONCLUSIONS Factors associated with ICS adherence appear to differ between African-American and white patients, suggesting that group-specific approaches are needed to improve adherence.


The Journal of Allergy and Clinical Immunology | 2015

Genetic ancestry influences asthma susceptibility and lung function among Latinos.

Maria Pino-Yanes; Neeta Thakur; Christopher R. Gignoux; Joshua M. Galanter; Lindsey A. Roth; Celeste Eng; Katherine K. Nishimura; Sam S. Oh; Hita Vora; Scott Huntsman; Elizabeth A. Nguyen; Donglei Hu; Katherine A. Drake; David V. Conti; Andres Moreno-Estrada; Karla Sandoval; Cheryl A. Winkler; Luisa N. Borrell; Fred Lurmann; Talat Islam; Adam Davis; Harold J. Farber; Kelley Meade; Pedro C. Avila; Denise Serebrisky; Kirsten Bibbins-Domingo; Michael LeNoir; Jean G. Ford; Emerita Brigino-Buenaventura; William Rodriguez-Cintron

BACKGROUND Childhood asthma prevalence and morbidity varies among Latinos in the United States, with Puerto Ricans having the highest and Mexicans the lowest. OBJECTIVE To determine whether genetic ancestry is associated with the odds of asthma among Latinos, and secondarily whether genetic ancestry is associated with lung function among Latino children. METHODS We analyzed 5493 Latinos with and without asthma from 3 independent studies. For each participant, we estimated the proportion of African, European, and Native American ancestry using genome-wide data. We tested whether genetic ancestry was associated with the presence of asthma and lung function among subjects with and without asthma. Odds ratios (OR) and effect sizes were assessed for every 20% increase in each ancestry. RESULTS Native American ancestry was associated with lower odds of asthma (OR = 0.72, 95% CI: 0.66-0.78, P = 8.0 × 10(-15)), while African ancestry was associated with higher odds of asthma (OR = 1.40, 95% CI: 1.14-1.72, P = .001). These associations were robust to adjustment for covariates related to early life exposures, air pollution, and socioeconomic status. Among children with asthma, African ancestry was associated with lower lung function, including both pre- and post-bronchodilator measures of FEV1 (-77 ± 19 mL; P = 5.8 × 10(-5) and -83 ± 19 mL; P = 1.1 x 10(-5), respectively) and forced vital capacity (-100 ± 21 mL; P = 2.7 × 10(-6) and -107 ± 22 mL; P = 1.0 x 10(-6), respectively). CONCLUSION Differences in the proportions of genetic ancestry can partially explain disparities in asthma susceptibility and lung function among Latinos.


The Journal of Allergy and Clinical Immunology | 2012

Effect of secondhand smoke on asthma control among black and Latino children

Sam S. Oh; Haig Tcheurekdjian; Lindsey A. Roth; Elizabeth A. Nguyen; Saunak Sen; Joshua M. Galanter; Adam Davis; Harold J. Farber; Frank D. Gilliland; Rajesh Kumar; Pedro C. Avila; Emerita Brigino-Buenaventura; Rocio Chapela; Jean G. Ford; Michael LeNoir; Fred Lurmann; Kelley Meade; Denise Serebrisky; Shannon Thyne; William Rodriguez-Cintron; Jose R. Rodriguez-Santana; L. Keoki Williams; Luisa N. Borrell; Esteban G. Burchard

BACKGROUND Among patients with asthma, the clinical effect and relative contribution of maternal smoking during pregnancy (in utero smoking) and current secondhand smoke (SHS) exposure on asthma control is poorly documented, and there is a paucity of research involving minority populations. OBJECTIVES We sought to examine the association between poor asthma control and in utero smoking and current SHS exposure among Latino and black children with asthma. METHODS We performed a case-only analysis of 2 multicenter case-control studies conducted from 2008-2010 with similar protocols. We recruited 2481 Latino and black subjects with asthma (ages 8-17 years) from the mainland United States and Puerto Rico. Ordinal logistic regression was used to estimate the effect of in utero smoking and current SHS exposures on National Heart, Lung, and Blood Institute-defined asthma control. RESULTS Poor asthma control among children 8 to 17 years of age was independently associated with in utero smoking (odds ratio [OR], 1.5; 95% CI, 1.1-2.0). In utero smoking through the mother was also associated with secondary asthma outcomes, including early-onset asthma (OR, 1.7; 95% CI, 1.1-2.4), daytime symptoms (OR, 1.6; 95% CI, 1.1-2.1), and asthma-related limitation of activities (OR, 1.6; 95% CI, 1.2-2.2). CONCLUSIONS Maternal smoking while in utero is associated with poor asthma control in black and Latino subjects assessed at 8-17 years of age.

Collaboration


Dive into the L. Keoki Williams's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Karen Wells

Henry Ford Health System

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Celeste Eng

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Rajesh Kumar

Children's Memorial Hospital

View shared research outputs
Top Co-Authors

Avatar

A. Levin

Henry Ford Health System

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Donglei Hu

University of California

View shared research outputs
Researchain Logo
Decentralizing Knowledge